Medline has confidentially filed for an initial public offering in the United States, paving the way for one of the major stock market flotations in 2025 that could value the medical supplies provider as high as $50 billion. The company has not determined the size of the offering, it said on Thursday, but Reuters reported last month the stock sale could fetch $5 billion. The offering would bolster the U.S. IPO market, which has staged a recovery this year due to a rally in equities and economic resilience. It could also be a major win for its private equity owners – Blackstone, Carlyle and Hellman & Friedman, which together acquired Medline in a deal worth $34 billion in 2021.
Read the full article: Medline Sets Stage for Blockbuster US IPO with Confidential Filing //
Source: https://www.msn.com/en-us/money/companies/medline-sets-stage-for-blockbuster-us-ipo-with-confidential-filing/ar-AA1wa4hU